CL2011000767A1 - Emulsion de aceite en agua que contiene (i) fase hidrofobica interna en cantidades desde 1 a 40 %, (ii)una fase hidrofilica externa desde 60 a 99 %, (iii) al menos un surfactante polimerico en cantidades desde 0,50 a 2,50 y (iv) al menos unprincipio activo insoluble en agua en cantidades desde 0,01 al 25 % por peso. - Google Patents
Emulsion de aceite en agua que contiene (i) fase hidrofobica interna en cantidades desde 1 a 40 %, (ii)una fase hidrofilica externa desde 60 a 99 %, (iii) al menos un surfactante polimerico en cantidades desde 0,50 a 2,50 y (iv) al menos unprincipio activo insoluble en agua en cantidades desde 0,01 al 25 % por peso.Info
- Publication number
- CL2011000767A1 CL2011000767A1 CL2011000767A CL2011000767A CL2011000767A1 CL 2011000767 A1 CL2011000767 A1 CL 2011000767A1 CL 2011000767 A CL2011000767 A CL 2011000767A CL 2011000767 A CL2011000767 A CL 2011000767A CL 2011000767 A1 CL2011000767 A1 CL 2011000767A1
- Authority
- CL
- Chile
- Prior art keywords
- amounts
- water
- phase
- iii
- oil
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/345—Nitrofurans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Pregnancy & Childbirth (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Colloid Chemistry (AREA)
Abstract
Emulsión de aceite en agua que contiene (i) fase hidrofobica interna en cantidades desde 1 a 40 %, (ii)una fase hidrofilica externa desde 60 a 99 %, (iii) al menos un surfactante polimerico en cantidades desde 0,50 a 2,50 y (iv) al menos unprincipio activo insoluble en agua en cantidades desde 0,01al 25 % por peso.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08166058A EP2174650A1 (en) | 2008-10-08 | 2008-10-08 | Modified release emulsions for application to skin or vaginal mucosa |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2011000767A1 true CL2011000767A1 (es) | 2011-06-17 |
Family
ID=40340663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2011000767A CL2011000767A1 (es) | 2008-10-08 | 2011-04-06 | Emulsion de aceite en agua que contiene (i) fase hidrofobica interna en cantidades desde 1 a 40 %, (ii)una fase hidrofilica externa desde 60 a 99 %, (iii) al menos un surfactante polimerico en cantidades desde 0,50 a 2,50 y (iv) al menos unprincipio activo insoluble en agua en cantidades desde 0,01 al 25 % por peso. |
Country Status (19)
Country | Link |
---|---|
US (1) | US20110195944A1 (es) |
EP (2) | EP2174650A1 (es) |
JP (1) | JP2012505171A (es) |
KR (1) | KR20110067115A (es) |
CN (1) | CN102170862A (es) |
AR (1) | AR073801A1 (es) |
AU (1) | AU2009301275A1 (es) |
BR (1) | BRPI0920565A2 (es) |
CA (1) | CA2737255A1 (es) |
CL (1) | CL2011000767A1 (es) |
CO (1) | CO6361898A2 (es) |
EA (1) | EA201170555A1 (es) |
IL (1) | IL211681A0 (es) |
MA (1) | MA32687B1 (es) |
MX (1) | MX2011003696A (es) |
NZ (1) | NZ591919A (es) |
PE (1) | PE20110449A1 (es) |
WO (1) | WO2010040632A1 (es) |
ZA (1) | ZA201101818B (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10286056B2 (en) * | 2011-01-27 | 2019-05-14 | Glaxosmithkline Biologicals S.A. | Adjuvant nanoemulsions with crystallisation inhibitors |
CA2829241A1 (en) | 2011-04-01 | 2012-10-04 | University Of Florida Research Foundation, Inc. | Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics |
DE102011076869A1 (de) * | 2011-06-01 | 2012-12-06 | Beiersdorf Ag | Emulsionszubereitungen mit verbesserten rheologischen Eigenschaften |
EP3936133A1 (en) | 2011-11-23 | 2022-01-12 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
KR102009698B1 (ko) | 2011-12-20 | 2019-08-13 | 바이옴 테라퓨틱스 리미티드 | 진균 감염의 치료를 위한 국소 오일 조성물 |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20160058775A1 (en) * | 2013-04-12 | 2016-03-03 | Vyome Biosciences Pvt. Ltd. | Composition and formulation of antimicrobial agents, processes thereof and methods for treating microbial infections |
CA2942345C (en) * | 2014-03-12 | 2020-12-01 | Warner Chilcott Company, Llc | Low-dose estradiol cream |
WO2015179782A1 (en) | 2014-05-22 | 2015-11-26 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
RU2018133932A (ru) | 2016-04-01 | 2020-05-12 | Терапьютиксмд, Инк. | Фармацевтическая композиция стероидного гормона |
WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
CA3040422A1 (en) * | 2016-10-13 | 2018-04-19 | Catalent U.K. Swindon Zydis Limited | Lyophilized pharmaceutical compositions for vaginal delivery |
IL271596B1 (en) * | 2017-06-22 | 2024-03-01 | Viramal Ltd | An emulsion preparation that includes danzol for use in the treatment of bread mucosa conditions |
WO2019213473A1 (en) | 2018-05-04 | 2019-11-07 | The Procter & Gamble Company | Compositions and methods for treating vaginal dryness |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002058689A1 (en) * | 2000-12-05 | 2002-08-01 | Childrens Hospital Los Angeles | Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same |
CA2480225A1 (en) * | 2002-04-04 | 2003-10-16 | Eugene H. Gans | Methods for treating rosacea with pyridones |
US20060233721A1 (en) * | 2002-10-25 | 2006-10-19 | Foamix Ltd. | Foam containing unique oil globules |
US20060018937A1 (en) * | 2002-10-25 | 2006-01-26 | Foamix Ltd. | Steroid kit and foamable composition and uses thereof |
US20040087564A1 (en) * | 2002-10-31 | 2004-05-06 | Wright D. Craig | Delivery composition and method |
WO2007099396A2 (en) * | 2005-06-07 | 2007-09-07 | Foamix Ltd. | Antibiotic kit and composition and uses thereof |
US20070071705A1 (en) * | 2005-09-29 | 2007-03-29 | De Oliveira Monica A M | Topical anti-microbial compositions |
US20080075745A1 (en) * | 2006-09-21 | 2008-03-27 | Glenmark Pharmaceuticals Limited | Topical pharmaceutical compositions containing ciclopirox or a pharmaceutically acceptable salt thereof |
-
2008
- 2008-10-08 EP EP08166058A patent/EP2174650A1/en not_active Withdrawn
-
2009
- 2009-09-21 JP JP2011530445A patent/JP2012505171A/ja not_active Withdrawn
- 2009-09-21 EA EA201170555A patent/EA201170555A1/ru unknown
- 2009-09-21 PE PE2011000670A patent/PE20110449A1/es not_active Application Discontinuation
- 2009-09-21 BR BRPI0920565A patent/BRPI0920565A2/pt not_active IP Right Cessation
- 2009-09-21 NZ NZ591919A patent/NZ591919A/xx not_active IP Right Cessation
- 2009-09-21 EP EP09818802A patent/EP2331065A1/en not_active Withdrawn
- 2009-09-21 CN CN2009801391796A patent/CN102170862A/zh active Pending
- 2009-09-21 CA CA2737255A patent/CA2737255A1/en not_active Abandoned
- 2009-09-21 WO PCT/EP2009/062190 patent/WO2010040632A1/en active Application Filing
- 2009-09-21 MX MX2011003696A patent/MX2011003696A/es unknown
- 2009-09-21 US US12/998,331 patent/US20110195944A1/en not_active Abandoned
- 2009-09-21 KR KR1020117007601A patent/KR20110067115A/ko not_active Application Discontinuation
- 2009-09-21 AU AU2009301275A patent/AU2009301275A1/en not_active Abandoned
- 2009-10-08 AR ARP090103886A patent/AR073801A1/es unknown
-
2011
- 2011-03-09 ZA ZA2011/01818A patent/ZA201101818B/en unknown
- 2011-03-10 IL IL211681A patent/IL211681A0/en unknown
- 2011-04-01 MA MA33736A patent/MA32687B1/fr unknown
- 2011-04-06 CL CL2011000767A patent/CL2011000767A1/es unknown
- 2011-04-07 CO CO11043013A patent/CO6361898A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2009301275A1 (en) | 2010-04-15 |
US20110195944A1 (en) | 2011-08-11 |
ZA201101818B (en) | 2012-05-30 |
PE20110449A1 (es) | 2011-07-07 |
KR20110067115A (ko) | 2011-06-21 |
IL211681A0 (en) | 2011-06-30 |
MX2011003696A (es) | 2011-06-20 |
NZ591919A (en) | 2012-09-28 |
CA2737255A1 (en) | 2010-04-15 |
MA32687B1 (fr) | 2011-10-02 |
EA201170555A1 (ru) | 2011-12-30 |
EP2174650A1 (en) | 2010-04-14 |
BRPI0920565A2 (pt) | 2015-12-29 |
AR073801A1 (es) | 2010-12-01 |
WO2010040632A1 (en) | 2010-04-15 |
JP2012505171A (ja) | 2012-03-01 |
CN102170862A (zh) | 2011-08-31 |
AU2009301275A2 (en) | 2011-04-28 |
CO6361898A2 (es) | 2012-01-20 |
EP2331065A1 (en) | 2011-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2011000767A1 (es) | Emulsion de aceite en agua que contiene (i) fase hidrofobica interna en cantidades desde 1 a 40 %, (ii)una fase hidrofilica externa desde 60 a 99 %, (iii) al menos un surfactante polimerico en cantidades desde 0,50 a 2,50 y (iv) al menos unprincipio activo insoluble en agua en cantidades desde 0,01 al 25 % por peso. | |
ECSP088670A (es) | Sistema de administracion de plaguicidas | |
AR092403A1 (es) | Nanoparticula polimerica de finasterida y minoxidil, proceso de preparacion, suspension acuosa conteniendo la misma, composicion farmaceutica, y su uso | |
CR20140539A (es) | Preparación que contiene por lo menos un fungicida conazólico | |
AR065065A1 (es) | Composicion agroquimica liquida que contiene compuesto hidrofobico agroquimicamente activo | |
BRPI0907480A2 (pt) | emulsões de óleo em água estabilizadas incluindo ingredientes agricolamente ativos | |
CR11747A (es) | Microemulsion mejorada que tiene un amplio rango de aplicacion | |
DOP2010000318A (es) | Formulaciones mejoradas para ingredientes farmaceuticos activos de permeabilidad deficiente | |
CL2010001619A1 (es) | Composiciones que comprenden una silicona de formula definida y un componente adicional; metodo para formular dichas composiciones; y emulsiones acuosas y no acuosas que comprenden a dichas composiciones (div. sol. n° 656-07). | |
CO6251306A2 (es) | Fabricacion procesamiento empaque y administracion de una bebida utilizando agua activada electroquimicamente | |
ATE493970T1 (de) | Konservierungsmittelfreie augenlösung auf prostaglandin-basis | |
CL2012001682A1 (es) | Composición antitranspirante anhidra líquida que comprende a) un vehículo e la forma de un disolvente eutectico profundo, que comprende i) al menos un miembro elegido de un catión y de un ion anfotero y ii) un donador de enlace de hidrógeno y b) al menos un ingrediente activo antitranspirante; un método de uso de la composición. | |
BRPI0906231A2 (pt) | composição de emulsão de água em óleo de alta fase interna, composição para o chuveiro ou a banheira e método para o fornecimento de um agene ativo para um consumidor. | |
AR071561A1 (es) | Formulaciones de emulsion de pickering | |
CU23814A3 (es) | Emulsión intravenosa de butilftalida y aplicación de la misma | |
GT200800247A (es) | Papel impregnado con principios activos insecticidas | |
CL2013003128A1 (es) | Composición herbicida que comprende a) una fase de aceite discontinua que comprende un principio activo y un solvente orgánico inmiscible en agua, b) una fase acuosa continua que comprende una sal de glifosato y agua, y c) al menos dos tensioactivos emulsionantes de copolímero en bloque; método de preparación. | |
AR071568A1 (es) | Composicion de suspension pesticida acuosa | |
CL2008002780A1 (es) | Combinacion de principios activos que contienen al menos un compuesto derivado de 5h-furan-2-ona y al menos un principio activo de los neonicotinoides; uso de dicha combinación; procedimiento para combatir animales nocivos. | |
AR086395A1 (es) | Envase para el tratamiento de patologias | |
AR071557A1 (es) | Composiciones pesticidas | |
CL2015001565A1 (es) | Composición, en forma de suspensión acuosa, que comprende al menos un compuesto de triazina, un principio activo adicional y uno o más tensioactivos; kit que comprende la composición; método de preparación y uso de un tesioactivo. | |
BR112012006056A2 (pt) | forma de dosagem | |
PE20081443A1 (es) | Formas de dosificacion en microemulsion de valsartan, y metodos para elaborarlas | |
AR082771A1 (es) | Composicion de formulacion agroquimica |